Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC).

Giersing BK, Modjarrad K, Kaslow DC, Okwo-Bele JM, Moorthy VS.

Vaccine. 2016 Jun 3;34(26):2863-4. doi: 10.1016/j.vaccine.2016.04.041. Epub 2016 Apr 21. No abstract available.

2.

Progress toward regional measles elimination - worldwide, 2000-2014.

Perry RT, Murray JS, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1246-51. doi: 10.15585/mmwr.6444a4.

3.

Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa.

Okwo-Bele JM, LaForce FM, Borrow R, Preziosi MP.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S389-90. doi: 10.1093/cid/civ592. No abstract available.

4.

Final results from a pivotal phase 3 malaria vaccine trial.

Moorthy VS, Okwo-Bele JM.

Lancet. 2015 Jul 4;386(9988):5-7. doi: 10.1016/S0140-6736(15)60767-X. Epub 2015 Apr 23. No abstract available.

PMID:
25913271
5.

World Health Organization perspectives on the contribution of the Global Alliance for Vaccines and Immunization on reducing child mortality.

Bustreo F, Okwo-Bele JM, Kamara L.

Arch Dis Child. 2015 Feb;100 Suppl 1:S34-7. doi: 10.1136/archdischild-2013-305693.

PMID:
25613965
6.

Progress toward regional measles elimination--worldwide, 2000-2013.

Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 14;63(45):1034-8.

7.

Ebola virus disease in the Democratic Republic of Congo.

Maganga GD, Kapetshi J, Berthet N, Kebela Ilunga B, Kabange F, Mbala Kingebeni P, Mondonge V, Muyembe JJ, Bertherat E, Briand S, Cabore J, Epelboin A, Formenty P, Kobinger G, González-Angulo L, Labouba I, Manuguerra JC, Okwo-Bele JM, Dye C, Leroy EM.

N Engl J Med. 2014 Nov 27;371(22):2083-91. doi: 10.1056/NEJMoa1411099. Epub 2014 Oct 15.

8.

Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?

Lydon P, Gandhi G, Vandelaer J, Okwo-Bele JM.

Bull World Health Organ. 2014 May 1;92(5):382-4. doi: 10.2471/BLT.13.130146. Epub 2014 Feb 7. No abstract available.

9.

The decade of vaccines global vaccine action plan: shaping immunization programmes in the current decade.

Cherian T, Okwo-Bele JM.

Expert Rev Vaccines. 2014 May;13(5):573-5. doi: 10.1586/14760584.2014.897618. Epub 2014 Mar 28.

PMID:
24678869
10.

Global control and regional elimination of measles, 2000-2012.

Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):103-7.

11.

Preface.

Temmerman M, Okwo-Bele JM.

Vaccine. 2014 Mar 20;32(14):1523-4. doi: 10.1016/j.vaccine.2014.01.050. Epub 2014 Jan 28. No abstract available.

PMID:
24480026
12.

Malaria vaccine technology roadmap.

Moorthy VS, Newman RD, Okwo-Bele JM.

Lancet. 2013 Nov 23;382(9906):1700-1. doi: 10.1016/S0140-6736(13)62238-2. Epub 2013 Nov 14. No abstract available.

PMID:
24239252
13.

Assessment of the RTS,S/AS01 malaria vaccine.

Moorthy VS, Newman RD, Duclos P, Okwo-Bele JM, Smith PG.

Lancet Infect Dis. 2013 Apr;13(4):280-2. doi: 10.1016/S1473-3099(13)70047-1. Epub 2013 Mar 1. No abstract available.

PMID:
23454165
14.

The expanded programme on immunization: a lasting legacy of smallpox eradication.

Okwo-Bele JM, Cherian T.

Vaccine. 2011 Dec 30;29 Suppl 4:D74-9. doi: 10.1016/j.vaccine.2012.01.080. Review.

PMID:
22486980
15.

Global Immunization Vision and Strategy (GIVS): a mid-term analysis of progress in 50 countries.

Kamara L, Lydon P, Bilous J, Vandelaer J, Eggers R, Gacic-Dobo M, Meaney W, Okwo-Bele JM.

Health Policy Plan. 2013 Jan;28(1):11-9. doi: 10.1093/heapol/czs020. Epub 2012 Mar 12.

16.

Integrating immunization with other health interventions for greater impact: the right strategic choice.

Okwo-Bele JM.

J Infect Dis. 2012 Mar;205 Suppl 1:S4-5. doi: 10.1093/infdis/jir800. No abstract available.

17.

A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS).

Brown DW, Burton A, Gacic-Dobo M, Karimov RI, Vandelaer J, Okwo-Bele JM.

BMC Public Health. 2011 Oct 14;11:806. doi: 10.1186/1471-2458-11-806.

18.

Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine.

LaForce FM, Okwo-Bele JM.

Health Aff (Millwood). 2011 Jun;30(6):1049-57. doi: 10.1377/hlthaff.2011.0328.

19.

Avoiding complacency and maintaining progress in routine immunization.

Brown DW, Karimov R, Gacic-Dobo M, Burton A, Okwo-Bele JM.

Int Health. 2011 Mar;3(1):1-2. doi: 10.1016/j.inhe.2010.12.003.

PMID:
24038043
20.

Establishing global policy recommendations: the role of the Strategic Advisory Group of Experts on immunization.

Duclos P, Okwo-Bele JM, Salisbury D.

Expert Rev Vaccines. 2011 Feb;10(2):163-73. doi: 10.1586/erv.10.171. Review.

PMID:
21332266
Items per page

Supplemental Content

Loading ...
Write to the Help Desk